Resultats globals: 2 registres trobats en 0.01 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
27 p, 1.5 MB Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium / Hässler, Signe (Hôpital Pitié-Salpêtrière) ; Bachelet, Delphine (Hôpital Bichat) ; Duhaze, Julianne (CHU Ste-Justine Research Center) ; Szely, Natacha (Paris-Sud University) ; Gleizes, Aude (Le Kremlin-Bicêtre Hospital) ; Hacein-Bey Abina, Salima (Paris-Descartes-Sorbonne-Cite University) ; Aktas, Orhan (University of Düsseldorf) ; Auer, Michael (Innsbruck Medical University) ; Avouac, Jerôme (Cochin Hospital) ; Birchler, Mary (GlaxoSmithKline (Estats Units d'Amèrica)) ; Bouhnik, Yoram (GETAID (França)) ; Brocq, Olivier (Princess Grace Hospital) ; Buck-Martin, Dorothea (Technische Universität München) ; Cadiot, Guillaume (University Hospital of Reims) ; Carbonnel, Franck (Hôpital Kremlin-Bicêtre) ; Chowers, Yehuda (Rambam Health Care Campus) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Derfuss, Tobias (University Hospital Basel (Basilea, Suïssa)) ; Sikkema, Dan (University of Amsterdam) ; Donnellan, Naoimh (Ipsen Biopharm (Regne Unit)) ; Doukani, Abiba (Sorbonne Université) ; Guger, Michael (Kepler University Hospital) ; Hartung, Hans-Peter (University of Düsseldorf) ; Kubala Havrdova, Eva (Charles University and General University Hospital, Prague, Czech Republic) ; Hemmer, Bernhard (Munich Cluster for Systems Neurology) ; Huizinga, Tom (Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands) ; Ingenhoven, Kathleen (University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany) ; Hyldgaard-Jensen, Poul Erik (Copenhagen University Hospital Rigshospitalet) ; Jury, Elizabeth C. (University College London) ; Khalil, Michael (Medical University of Graz) ; Kieseier, Bernd (University of Düsseldorf) ; Lindberg, Raija (University Hospital Basel (Basilea, Suïssa)) ; Loercher, Amy (GlaxoSmithKline (Estats Units d'Amèrica)) ; Maggi, Enrico (Bambino Gesù Children's Hospital) ; Manson, Jessica (University College London Hospital) ; Mauri, Claudia (University College London) ; Mohand Oumoussa, Badreddine (Sorbonne Université) ; Montalban, Xavier (St. Michael's Hospital) ; Nachury, Maria (University Hospital of Lille (França)) ; Nytrova, Petra (Charles University. Faculty of Medicine in Hradec Králové) ; Richez, Christophe (Bordeaux University) ; Ryner, Malin (Karolinska Institutet (Estocolm, Suècia)) ; Sellebjerg, Finn (Copenhagen University Hospital Rigshospitalet) ; Sievers, Claudia (University Hospital Basel (Basilea, Suïssa)) ; Sikkema, Dan (Quanterix Corporation (Estats Units d'Amèrica)) ; Soubrier, Martin (University Hospital of Clermont Ferrand) ; Tourdot, Sophie (Paris-Sud University) ; Trang, Caroline (CHU de Nantes) ; Vultaggio, Alessandra (Università di Firenze) ; Warnke, Clemens (University Hospital Köln) ; Spindeldreher, Sebastian (Integrated Biologix GmbH (Suïssa)) ; Dönnes, Pierre (SciCross AB (Suècia)) ; Hickling, Timothy P. (Pfizer (Estats Units d'Amèrica)) ; Hincelin Mery, Agnès (Sanofi, Chilly-Mazarin, France) ; Allez, Matthieu (Hôpital Saint-Louis, AP-HP) ; Deisenhammer, Florian (Innsbruck Medical University) ; Fogdell-Hahn, Anna (Karolinska Institutet (Estocolm, Suècia)) ; Mariette, Xavier (Université Paris-Saclay) ; Pallardy, Marc (Paris-Sud University) ; Broët, Philippe (Paris-Sud University Hospitals) ; Universitat Autònoma de Barcelona
Biopharmaceutical products (BPs) are widely used to treat autoimmune diseases, but immunogenicity limits their efficacy for an important proportion of patients. Our knowledge of patient-related factors influencing the occurrence of antidrug antibodies (ADAs) is still limited. [...]
2020 - 10.1371/journal.pmed.1003348
PLoS Medicine, Vol. 17 (october 2020)  
2.
8 p, 676.9 KB Off-label use of rituximab for systemic lupus erythematosus in Europe / Rydén-Aulin, Monica (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Boumpas, Dimitrios (Kapodestrian University of Athens) ; Bultink, Irene (Amsterdam Rheumatology and Immunology Center) ; Callejas Rubio, Jose Luis (Hospital Universitario San Cecilio (Granada)) ; Caminal-Montero, Luis (Hospital Universitario Central de Asturias) ; Castro, Antoni (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Colodro Ruiz, Agustín ; Doria, Andrea (University of Padova) ; Dörner, Thomas (Charite Universitaetsmedizin Berlin) ; González-Echávarri, Cristina (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Gremese, Elisa (Institute of Rheumatology and Affine Sciences (IRSA), Catholic University of the Sacred Heart) ; Houssiau, Frederic A. (Université Catholique de Louvain) ; Huizinga, Tom ; Inanç, Murat (Istanbul University) ; Isenberg, David (University College London) ; Iuliano, Annamaria (San Camillo Forlanini Hospital) ; Jacobsen, Søren (University of Copenhagen) ; Jimenéz-Alonso, Juan (Hospital Universitario Virgen de las Nieves (Granada)) ; Kovács, Lászlo (University of Szeged. Albert Szent-Györgyi Health Centre) ; Mariette, Xavier (Université Paris-Sud) ; Mosca, Marta (Rheumatology Unit, Pisa) ; Nived, Ola (Skåne University Hospital (Suècia)) ; Oristrell, Joaquim (Universitat Autònoma de Barcelona. Departament de Medicina) ; Ramos-Casals, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rascón, Javier ; Ruiz-Irastorza, Guillermo (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Sáez-Comet, Luis (Hospital Universitario Miguel Servet (Saragossa)) ; Salvador Cervelló, Gonzalo (Hospital Universitari i Politècnic La Fe (València)) ; Sebastiani, Gian Domenico (Ospedale San Camillo) ; Squatrito, Danilo (University of Florence) ; Szücs, Gabriella (Institute of Medicine, University of Debrecen) ; Voskuyl, Alexandre (Amsterdam Rheumatology and Immunology Center (ARC)) ; van Vollenhoven, Ronald (Amsterdam Rheumatology and Immunology Center ARC)
Rituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the characteristics of patients receiving RTX with those receiving conventional therapy. [...]
2016 - 10.1136/lupus-2016-000163
Lupus Science & Medicine, Vol. 3 (september 2016)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.